ATLASCytek Biosciences (CTKB) earnings date: Nov 4, 2026
Cytek Biosciences (CTKB) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026 (confirmed), after the close. Analysts expect EPS of -$0.08. Free email alerts for this report are just below.
Source: company filings and exchange data · Updated Nov 3, 2026
ATLAS view on CTKB
| Last price | $6.01 (+4.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.2% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Cytek Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get an email before and after Cytek Biosciences reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountCTKB earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.08 |
| Last report | Jul 30, 2026 · Beat |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | +12.0% |
| Average move around a report | ±4.1% (last 4) |
| Sector | Healthcare · Medical Devices |
Cytek Biosciences earnings history: last 4 reports
Cytek Biosciences last reported on Jul 30, 2026: EPS of $2.62 against an estimate of $2.51 (+4.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 30, 2026 | $2.51 | $2.62 | +4.4% | Beat | -3.7% |
| Jul 14, 2026 | $0.09 | $0.13 | +44.4% | Beat | +3.1% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | +2.9% |
| May 7, 2026 | -$0.08 | -$0.10 | -25.0% | Miss | -6.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CTKB
See the fair value, the probability range and the earnings history of Cytek Biosciences on its ATLAS page.
Cytek Biosciences (CTKB) stock analysisPlans from €3.99 a month.
Cytek Biosciences earnings: frequently asked questions
When does Cytek Biosciences (CTKB) report earnings?
Cytek Biosciences is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CTKB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.08 per share (USD). Estimates can change before the report.
How often does CTKB beat earnings estimates?
Of its last 4 reports with a recorded result, Cytek Biosciences beat the EPS estimate 3 times; the average surprise was +12.0%. Past results do not predict the next one.
How much does CTKB move around earnings?
Over its last 4 reports the stock moved an average of 4.1% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Cytek Biosciences beat earnings estimates last quarter?
Cytek Biosciences last reported on Jul 30, 2026: EPS of $2.62 against an estimate of $2.51 (+4.4% surprise), a beat.
How much does CTKB usually move in a day?
On a normal trading day the ATLAS model puts CTKB’s one-day range at about ±3.2%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer